PDB Short entry for 2MAI HEADER ANTIBIOTIC 09-JUL-13 2MAI TITLE NMR STRUCTURE OF LASSOMYCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: LASSOMYCIN; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LENTZEA KENTUCKYENSIS; SOURCE 3 ORGANISM_TAXID: 360086 KEYWDS LASSO, ANTIBIOTIC EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR E.GAVRISH,C.S.SIT,O.KANDROR,A.SPOERING,A.PEOPLES,L.LING,A.FETTERMAN, AUTHOR 2 D.HUGHES,S.CAO,A.BISSELL,H.TORREY,T.AKOPIAN,A.MUELLER,S.EPSTEIN, AUTHOR 3 A.GOLDBERG,J.CLARDY,K.LEWIS REVDAT 2 14-MAY-14 2MAI 1 JRNL REVDAT 1 07-MAY-14 2MAI 0 JRNL AUTH E.GAVRISH,C.S.SIT,S.CAO,O.KANDROR,A.SPOERING,A.PEOPLES, JRNL AUTH 2 L.LING,A.FETTERMAN,D.HUGHES,A.BISSELL,H.TORREY,T.AKOPIAN, JRNL AUTH 3 A.MUELLER,S.EPSTEIN,A.GOLDBERG,J.CLARDY,K.LEWIS JRNL TITL LASSOMYCIN, A RIBOSOMALLY SYNTHESIZED CYCLIC PEPTIDE, KILLS JRNL TITL 2 MYCOBACTERIUM TUBERCULOSIS BY TARGETING THE ATP-DEPENDENT JRNL TITL 3 PROTEASE CLPC1P1P2. JRNL REF CHEM.BIOL. V. 21 509 2014 JRNL REFN ISSN 1074-5521 JRNL PMID 24684906 JRNL DOI 10.1016/J.CHEMBIOL.2014.01.014 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MAI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-AUG-13. REMARK 100 THE RCSB ID CODE IS RCSB103412. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 313 REMARK 210 PH : 7 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 4 MM [U-100% 13C; U-100% 15N] REMARK 210 PROTEIN, DMSO REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D CBCA(CO)NH; REMARK 210 3D HNCO; 3D HNCACB; 3D HCCH- REMARK 210 TOCSY; 3D HNHA; 3D 1H-15N TOCSY; REMARK 210 3D 1H-13C NOESY; 3D 1H-15N NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 2.1 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : ALL CALCULATED STRUCTURES REMARK 210 SUBMITTED REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (RES=RESIDUE NAME; REMARK 470 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 470 MODELS 1-20 REMARK 470 RES CSSEQI ATOMS REMARK 470 GLY A 1 N REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 3 -74.04 -102.93 REMARK 500 1 PHE A 6 104.47 -179.35 REMARK 500 2 ARG A 3 -74.56 -105.82 REMARK 500 2 GLN A 9 -72.04 -58.64 REMARK 500 3 ARG A 3 -74.59 -96.12 REMARK 500 3 GLN A 9 -73.44 -58.80 REMARK 500 3 ARG A 14 -62.16 -106.99 REMARK 500 4 ARG A 3 -74.70 -109.73 REMARK 500 4 PHE A 6 117.81 -178.05 REMARK 500 4 GLN A 9 -71.50 -58.76 REMARK 500 4 ARG A 14 -63.12 -92.30 REMARK 500 5 ARG A 3 -70.93 -106.17 REMARK 500 5 PHE A 6 100.18 -179.20 REMARK 500 5 ARG A 13 71.29 52.48 REMARK 500 6 ARG A 3 -72.87 -114.42 REMARK 500 6 PHE A 6 -179.08 -178.94 REMARK 500 6 VAL A 11 149.98 -171.39 REMARK 500 7 ARG A 3 -74.15 -120.40 REMARK 500 7 PHE A 6 98.70 180.00 REMARK 500 7 ARG A 14 15.59 -142.60 REMARK 500 8 ARG A 3 -66.00 -107.05 REMARK 500 8 LEU A 5 47.76 -89.90 REMARK 500 8 PHE A 6 116.33 66.37 REMARK 500 8 ALA A 7 178.31 -56.11 REMARK 500 8 VAL A 11 142.55 -171.96 REMARK 500 8 ARG A 14 24.79 -152.56 REMARK 500 9 ARG A 3 -73.77 -91.74 REMARK 500 9 PHE A 6 104.88 -179.47 REMARK 500 9 ARG A 13 82.44 51.86 REMARK 500 10 ARG A 3 -72.40 -128.03 REMARK 500 11 ARG A 3 -69.97 -125.35 REMARK 500 11 ARG A 13 60.52 61.73 REMARK 500 12 ARG A 3 -72.70 -127.94 REMARK 500 12 GLN A 9 -73.39 -58.66 REMARK 500 13 ARG A 3 -64.33 -137.50 REMARK 500 13 PHE A 6 -178.53 -176.59 REMARK 500 14 ARG A 3 -74.45 -111.09 REMARK 500 14 PHE A 6 108.20 -179.24 REMARK 500 14 GLN A 9 -70.07 -58.71 REMARK 500 14 ARG A 14 -74.42 -75.46 REMARK 500 15 ARG A 3 -73.56 -128.97 REMARK 500 15 PHE A 6 -179.21 -172.78 REMARK 500 16 ARG A 3 -74.59 -119.69 REMARK 500 16 PHE A 6 113.59 -178.14 REMARK 500 16 GLN A 9 -74.59 -58.79 REMARK 500 17 ARG A 3 -60.74 -130.99 REMARK 500 17 PHE A 6 117.89 -177.95 REMARK 500 18 ARG A 3 -72.82 -119.27 REMARK 500 18 GLN A 9 -72.61 -56.04 REMARK 500 18 ARG A 14 27.63 -143.93 REMARK 500 REMARK 500 THIS ENTRY HAS 54 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19355 RELATED DB: BMRB DBREF 2MAI A 1 16 PDB 2MAI 2MAI 1 16 SEQRES 1 A 16 GLY LEU ARG ARG LEU PHE ALA ASN GLN LEU VAL GLY ARG SEQRES 2 A 16 ARG ASN ILM MODRES 2MAI ILM A 16 ILE METHYL L-ISOLEUCINATE HET ILM A 16 24 HETNAM ILM METHYL L-ISOLEUCINATE FORMUL 1 ILM C7 H15 N O2 LINK C ASN A 15 N ILM A 16 1555 1555 1.37 LINK CA GLY A 1 ND2 ASN A 8 1555 1555 1.55 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000